文献速递糖尿病

持续葡萄糖监测预测自身抗体阳性儿童进展为糖尿病

Continuous Glucose Monitoring Predicts Progression to Diabetes in Autoantibody Positive Children.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

该研究基于DAISY前瞻性队列,分析23例胰岛自身抗体阳性(Ab+)儿童的纵向CGM数据,其中8例在中位随访17.7年后进展为糖尿病。进展者基线血糖波动性、日间传感器平均葡萄糖及曲线下面积均显著高于非进展者,且>140 mg/dL时间百分比≥18%对糖尿病预测具有75%敏感性和100%特异性。

要点

  • Ab+儿童CGM中>140 mg/dL时间≥18%可预测进展为糖尿病。
  • 进展者基线血糖波动性及日间血糖显著高于非进展者。
  • >140或>160 mg/dL时间百分比预测糖尿病的ROC曲线AUC为0.85。

核心结论

  • CGM中>140 mg/dL时间百分比≥18%可预测Ab+儿童进展为糖尿病。

研究设计与样本

  • DAISY前瞻性队列研究,分析23例有纵向CGM数据的胰岛自身抗体阳性儿童。

主要发现

  • 23例中8例进展为糖尿病,中位年龄13.8岁,中位随访17.7年(IQR 14.6–22.0年)。
  • 进展者基线血糖标准差29 vs 21 mg/dL(P=0.047),日间传感器平均122 vs 106 mg/dL(P=0.02),日间AUC 470,370 vs 415,465(P=0.047)。
  • 进展者>140 mg/dL时间24% vs 8%,>160 mg/dL时间12% vs 3%(均P=0.005)。
  • ROC分析显示>140或>160 mg/dL时间百分比预测糖尿病的AUC为0.85。

关键数值与推荐

  • >140 mg/dL时间百分比 cutoff 18%:敏感性75%,特异性100%,阳性预测值100%。

临床怎么用

  • 对胰岛自身抗体阳性儿童可考虑CGM评估血糖波动及高血糖时间以辅助预测T1D进展。

局限性

  • 样本量小(23例),部分非进展者随访延长后可能进展为糖尿病,预测值可能变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Accurate measures are needed for the prediction and diagnosis of type 1 diabetes (T1D) in at-risk persons. OBJECTIVE: The purpose of this study was to explore the value of continuous glucose monitoring (CGM) in predicting T1D onset. DESIGN AND SETTING: The Diabetes Autoimmunity Study in the Young (DAISY) prospectively follows children at increased risk for development of islet autoantibodies (islet autoantibody positive; Ab+) and T1D. PARTICIPANTS: We analyzed 23 Ab+ participants with available longitudinal CGM data. MAIN OUTCOME MEASURE: CGM metrics as glycemic predictors of progression to T1D. RESULTS: Of 23 Ab+ participants with a baseline CGM, 8 progressed to diabetes at a median age of 13.8 years during a median follow-up of 17.7 years (interquartile range, 14.6 to 22.0 years). Compared with nonprogressors, participants who progressed to diabetes had significantly increased baseline glycemic variability (SD, 29 vs 21 mg/dL; P = 0.047), daytime sensor average (122 vs 106 mg/dL; P = 0.02), and daytime sensor area under the curve (AUC, 470,370 vs 415,465; P = 0.047). They spent 24% of time at >140 mg/dL and 12% at >160 mg/dL compared with, respectively, 8% and 3% for nonprogressors (both P = 0.005). A receiver-operating characteristic curve analysis showed an AUC of 0.85 for percentage of time spent at >140 or 160 mg/dL. The cutoff of 18% time spent at >140 mg/dL had 75% sensitivity, 100% specificity, and a 100% positive predictive value for diabetes prediction, although these values could change because some nonprogressors may develop diabetes with longer follow-up. CONCLUSIONS: Eighteen percent or greater CGM time spent at >140 mg/dL predicts progression to diabetes in Ab+ children.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Steck AK, Dong F, Taki I, et al. Continuous Glucose Monitoring Predicts Progression to Diabetes in Autoantibody Positive Children. J Clin Endocrinol Metab. 2019. PMID: 30844073. doi:10.1210/jc.2018-02196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。